Prevalence of Hepatitis C Virus Infection among Hemodialysis Patients at a Tertiary-Care Hospital in Mexico City, Mexico-Reference-Cited by-同舟云学术

Prevalence of Hepatitis C Virus Infection among Hemodialysis Patients at a Tertiary-Care Hospital in Mexico City, Mexico

Published:2004-09 Issue:9 Volume:42 Page:4321-4322
ISSN:0095-1137
Container-title:Journal of Clinical Microbiology
language:en
Short-container-title:J Clin Microbiol

Author:

Méndez-Sánchez Nahum¹,Motola-Kuba Daniel¹,Chavez-Tapia Norberto C.¹,Bahena Jesús¹,Correa-Rotter Ricardo¹,Uribe Misael¹

Affiliation:

1. Departments of Biomedical Research and Gastroenterology and Liver Unit and Hemodialysis Unit, Medica Sur Clinic and Foundation, Mexico City, Mexico

Abstract

ABSTRACT We determined the prevalence of hepatitis C virus (HCV) in hemodialysis patients by antibody testing and HCV RNA determination by PCR. A total of 149 patients with kidney failure with replacement therapy were tested. The prevalence of anti-HCV was 6.7% (10 of 149 patients), and viremia was detectable in 8 of 149 (5%) patients. Three of 149 patients (2%) were anti-HCV negative with detectable HCV RNA.

Publisher

American Society for Microbiology

Subject

Microbiology (medical)

Link

https://journals.asm.org/doi/pdf/10.1128/JCM.42.9.4321-4322.2004

Reference25 articles.

1. Alter, M. J., D. Kruszon-Moran, O. V. Nainan, G. M. McQuillan, F. Gao, L. A. Moyer, R. A. Kaslow, and H. S. Margolis. 1999. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N. Engl. J. Med.341:556-562.

2. Bukh, J., P. Wantzin, K. Krogsgaard, F. Knudsen, R. H. Purcell, and R. H. Miller. 1993. High prevalence of hepatitis C virus (HCV) RNA in dialysis patients: failure of commercially available antibody tests to identify a significant number of patients with HCV infection. Copenhagen Dialysis HCV Study Group. J. Infect. Dis.168:1343-1348.

3. Cotler, S. J., G. Diaz, S. Gundlapalli, S. Jakate, A. Chawla, D. Mital, S. Jensik, and D. M. Jensen. 2002. Characteristics of hepatitis C in renal transplant candidates. J. Clin. Gastroenterol.35:191-195.

4. Dalekos, G. N., D. S. Boumba, K. Katopodis, E. Zervou, G. Sferopoulos, M. Elisaf, E. V. Tsianos, and K. C. Siamopoulos. 1998. Absence of HCV viraemia in anti-HCV-negative haemodialysis patients. Nephrol. Dial. Transplant.13:1804-1806.

5. Dal Molin, G., C. Tiribelli, and C. Campello. 2003. A rational use of laboratory tests in the diagnosis and management of hepatitis C virus infection. Ann. Hepatol.2:76-83.

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Detecting the Prevalence of Hepatitis C Virus among Iraqi People;International Journal of Biomedicine;2023-06-05

2. Prevalent coinfection and associated factors for Hepatitis B, Hepatitis C, and Human Immunodeficiency Virus in patients submitted to renal replacement therapy: A cross-sectional study of 21 dialysis units in the State of Mexico;PLOS ONE;2022-12-01

3. Molecular characterization and genotyping of hepatitis C virus from Sudanese end-stage renal disease patients on haemodialysis;BMC Infectious Diseases;2022-11-14

4. Micro‐elimination of Hepatitis C in Low‐ and Middle‐Income Settings: Challenges and Windows of Opportunity;Clinical Liver Disease;2021-08-10

5. A cross sectional study of the risk factors of hepatitis C infection in North Egypt;VirusDisease;2021-03